In addition, a DDR tyrosine kinase inhibitor (DDR1-IN-1) also significantly suppressed the proliferation of melanoma cell line M10 in vitro and in C8161 and SKMEL5 xenograft tumor models in vivo [232]. This evidence concerns the gene DDR1 and melanoma.